PSF International Growth Portfolio OCSE:NOVO B Holdings History
PSF International Growth Portfolio's Novo Nordisk AS Holding Summary
As of 2022-12-31, PSF International Growth Portfolio held 27,826.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr1.89 Mil. This investment constitutes 2.68% of their stock portfolio, and PSF International Growth Portfolio now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.
The initial trade took place in 2019Q3. And since then PSF International Growth Portfolio has made 5 purchases of OCSE:NOVO B, at an average price of kr225.58, for a total of 58,090.00 shares. In addition, there have been 4 sales at an average price of kr283.02 for 30,264.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr414.60, PSF International Growth Portfolio's estimated gain on his OCSE:NOVO B holdings is kr7.00 Mil, reflecting a 53.40% gain to date.
PSF International Growth Portfolio OCSE:NOVO B (kr414.60) Holding Chart
PSF International Growth Portfolio OCSE:NOVO B (kr414.60) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price kr-/Share | ||
| Shares Sold | 0 | Average Price kr-/Share | ||
| Current Price kr0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
